Oasmia Pharmaceutical AB Valuation

Oasmia Pharmaceutical Investor Information

The company has price-to-book ratio of 0.68. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Oasmia Pharmaceutical last dividend was issued on the 25th of March 2022. The entity had 1673:1223 split on the 15th of November 2019. Oasmia Pharmaceutical AB is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.

Oasmia Pharmaceutical Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Oasmia Pharmaceutical has an asset utilization ratio of 4.41 percent. This suggests that the Company is making $0.0441 for each dollar of assets. An increasing asset utilization means that Oasmia Pharmaceutical AB is more efficient with each dollar of assets it utilizes for everyday operations.

Oasmia Pharmaceutical Profitability Analysis

The company reported the revenue of 26.19 M. Net Loss for the year was (132.72 M) with loss before overhead, payroll, taxes, and interest of (15.25 M).

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.